The widely popular contraceptive drugs Yaz and Yasmin will remain on the market in Switzerland despite recent negative news regarding the two drugs. Two women in Switzerland have recently suffered adverse side effects from the drug, calling into question its safety. One of the women died while the other is now severely disabled.
The contraceptives were reviewed by Swissmedic, which has allowed the drug to remain on the market in Switzerland, stating that while this generation of Yaz and Yasmin has a higher risk of thrombosis, the risk remains within “reasonable limits.” The maker of the oral contraceptives, Bayer, has updated its information regarding the drug for medical professionals and patients.
The contraceptives Yaz and Yasmin are oral birth control pills that contain the progesterone drospirenone and the estrogen ethinyl estradiol and entered the market in 2001. Initial TV ads for the drug were very misleading as Yaz and Yasmin were advertised as being much safer than other oral contraceptives.
Progesterone drospirenone is not contained in any other oral contraceptive on the market. The progesterone in Yaz and Yasmin can lead to serious conditions in women with certain pre-existing medical conditions. The drospirenone can interfere with the body’s fluid regulating mechanism and result in increased potassium levels in the blood, a condition known as hyperkalemia. The condition leads to abnormal heart rhythms which interfere with circulation and lead to embolisms, strokes, and heart attacks.
The two women involved in the problems in Switzerland suffered from deep vein thrombosis, a form of severe blood clotting. DVT occurs when a blood clot forms in a deep vein, commonly affecting leg veins or the deep veins in the pelvis. On some occasions, DVT can affect the arms as well. The condition can be present with no symptoms, but often the affected extremity will be swollen, red, warm, painful, and the superficial veins will become engorged. Deep vein thrombosis is extremely dangerous because if the clot dislodges it can travel to the lungs and lead to a pulmonary embolism.
The presence of the progesterone drospirenone in Yaz and Yasmin has been touted as a benefit with ads implying that the drugs were not only safer but more effective than other contraceptives on the market – a claim that is false. The initial ads were pulled after warnings from the FDA, but new ads that lightly touched on the risks were still not at FDA standards, warranting further warnings. Between 2004 and 2008 the FDA received reports of at least 50 deaths that were linked to Yaz and Yasmin, most of them as a result of hyperkalemia.
If you or a loved one has experienced a serious side effect or symptoms of side effects related to Yaz, Yasmin or related birth control medications, contact Newsome Law Firm and fill out a case evaluation form today. Our team of attorneys has experience specific to complications associated with prescription medication recalls. Not only can they give you the legal guidance you need, they can help you get the compensation you deserve.